Found: 20
Select item for more details and to access through your institution.
Non-conventional dosing of oral anticancer agents in oncology and malignant haematology: a systematic review protocol.
- Published in:
- Systematic Reviews, 2017, v. 6, p. 1, doi. 10.1186/s13643-017-0636-y
- By:
- Publication type:
- Article
Frailty subgroup analysis of isatuximab with pomalidomide and dexamethasone in a UK‐wide real‐world cohort of relapsed myeloma patients.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 1, p. 162, doi. 10.1111/bjh.18672
- By:
- Publication type:
- Article
Myeloma clinical outcomes following the first wave of COVID‐19: results from the Thames Valley Cancer Alliance (UK).
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. e136, doi. 10.1111/bjh.17261
- By:
- Publication type:
- Article
Assessing the impact of lockdown: Fresh challenges for the care of haematology patients in the COVID‐19 pandemic.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 6, p. e224, doi. 10.1111/bjh.16782
- By:
- Publication type:
- Article
Carfilzomib therapy for relapsed myeloma: results of a UK multicentre experience.
- Published in:
- British Journal of Haematology, 2020, v. 188, n. 4, p. e57, doi. 10.1111/bjh.16324
- By:
- Publication type:
- Article
Efficacy of R‐GCVP in patients with late relapse of diffuse large B‐cell lymphoma.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 6, p. e191, doi. 10.1111/bjh.16071
- By:
- Publication type:
- Article
Long term outcomes in monoclonal gammopathy of renal significance.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 5, p. 706, doi. 10.1111/bjh.15987
- By:
- Publication type:
- Article
Resource implications of bortezomib therapy in a large UK cohort: An evaluation study.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 8, p. 1995, doi. 10.1177/1078155219866500
- By:
- Publication type:
- Article
Efficacy and tolerability of VCD chemotherapy in a UK real‐world dataset of elderly transplant‐ineligible newly diagnosed myeloma patients.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 4, p. 563, doi. 10.1111/ejh.13588
- By:
- Publication type:
- Article
Efficacy and infection morbidity of front‐line immuno‐chemotherapy in follicular lymphoma.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 5, p. 667, doi. 10.1111/ejh.13486
- By:
- Publication type:
- Article
Myeloma care adaptations in the UK during SARS‐CoV‐2 pandemic: Challenges and measurable outcomes.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 5, p. 662, doi. 10.1111/ejh.13479
- By:
- Publication type:
- Article
DPACE‐based chemotherapy in the era of myeloma novel agents: A UK multicentre study.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 2, p. 231, doi. 10.1111/ejh.13422
- By:
- Publication type:
- Article
Treatment-free interval as an additional measure of efficacy in a large UK dataset of transplant ineligible myeloma patients.
- Published in:
- PLoS ONE, 2020, v. 15, n. 2, p. 1, doi. 10.1371/journal.pone.0229469
- By:
- Publication type:
- Article
Consolidation following DPACE therapy improves outcomes in relapsed/refractory myeloma patients in the era of novel agents.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e254, doi. 10.1016/j.clml.2019.09.421
- By:
- Publication type:
- Article
Proteasome Inhibitor Based Induction Improves Outcomes Only in Transplant Eligible NDMM Patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e123, doi. 10.1016/j.clml.2017.03.223
- By:
- Publication type:
- Article
Total Dose But Not Combination of Bortezomib Regimen Influences Outcomes in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e78, doi. 10.1016/j.clml.2017.03.141
- By:
- Publication type:
- Article
To Treat or not to Treat: Hyperelderly Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e138, doi. 10.1016/j.clml.2017.03.249
- By:
- Publication type:
- Article
A systematic review of non-standard dosing of oral anticancer therapies.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Evaluation of the frailty characteristics and clinical outcomes according to the new frailty-based outcome prediction model (Myeloma Risk Profile-MRP) in a UK real-world cohort of elderly newly diagnosed Myeloma patients.
- Published in:
- PLoS ONE, 2022, v. 17, n. 1, p. 1, doi. 10.1371/journal.pone.0262388
- By:
- Publication type:
- Article
Clinical outcomes of bortezomib-based therapy in myeloma.
- Published in:
- PLoS ONE, 2018, v. 13, n. 12, p. 1, doi. 10.1371/journal.pone.0208920
- By:
- Publication type:
- Article